The Wall Street Journal: U.S. warnings about a rare risk of blindness linked to weight-loss drugs

Elnashra: U.S. regulatory agencies required manufacturers of popular weight-loss drugs, such as “Ozempic” and “Zepbound,” to include warnings on…
Machine translation of an attributed source excerpt. Consult the original report to verify details. Translated from original reporting in another language.


